Single Ascending Dose Study of Intraperitoneal Triferic (Ferric Pyrophosphate Citrate) in Patients on Chronic Peritoneal Dialysis
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Ferric pyrophosphate (Primary) ; Ferric pyrophosphate
- Indications Iron deficiency anaemia
- Focus Pharmacokinetics
- Sponsors Rockwell Medical Technologies
- 09 May 2019 According to a Rockwell Medical Technologies media release, data from this trial was presented at the 39th Annual Dialysis Conference in March 2019.
- 18 Mar 2019 According to a Rockwell Medical Technologies media release, the data from two studies including this study will be presented at the Annual Dialysis Conference, the largest multi-disciplinary conference on dialysis Mar 16-19 2019.
- 02 May 2018 According to a Rockwell Medical Technologies media release, data from this trial will be presented at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD) 2018.